Article Details

Vanda Pharmaceuticals (NASDAQ:VNDA) Stock Rating Lowered by Zacks Investment Research

Retrieved on: 2020-11-27 14:26:01

Tags for this article:

Click the tags to see associated articles and topics

Vanda Pharmaceuticals (NASDAQ:VNDA) Stock Rating Lowered by Zacks Investment Research. View article details on hiswai:

Excerpt

<b>WINTON GROUP</b> Ltd now owns 585,248 shares of the biopharmaceutical company's stock valued at $6,695,000 after acquiring an additional 21,725 ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up